Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL).
This report contains market size and forecasts of Idelalisib(CAL-101) in global, including the following market information:
Global Idelalisib(CAL-101) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Idelalisib(CAL-101) Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Idelalisib(CAL-101) companies in 2021 (%)
The global Idelalisib(CAL-101) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Idelalisib(CAL-101) include TCI, Biosynth Carbosynth, BOC Sciences, Focus Biomolecules, Adooq Bioscience, Selleck Chemicals, Enzo Biochem, Axon Medchem and BioVision, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Idelalisib(CAL-101) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Idelalisib(CAL-101) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Idelalisib(CAL-101) Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Idelalisib(CAL-101) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Idelalisib(CAL-101) Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Idelalisib(CAL-101) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Idelalisib(CAL-101) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Idelalisib(CAL-101) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Idelalisib(CAL-101) revenues share in global market, 2021 (%)
Key companies Idelalisib(CAL-101) sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Idelalisib(CAL-101) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
TCI
Biosynth Carbosynth
BOC Sciences
Focus Biomolecules
Adooq Bioscience
Selleck Chemicals
Enzo Biochem
Axon Medchem
BioVision
Santa Cruz Biotechnology
Clearsynth
LGC
LKT Laboratories
Shimadzu
Aladdin
Cayman Chemical